Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Small (Weinheim an Der Bergstrasse, Germany)
|
July 19, 2012
Microarray with micro- and nano-topographies enables identification of the optimal topography for directing the differentiation of primary murine neural progenitor cells
Aung Aung Kywe Moe, Mona Suryana, Guillaume Marcy, et al.
Journal of Clinical Medicine
|
December 24, 2021
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
Gili Kenet, Yeu-Chin Chen, Gillian Lowe, et al.
The New England Journal of Medicine
|
October 2, 2004
Pure red-cell aplasia and epoetin therapy
Charles L Bennett, Stefano Luminari, Allen R Nissenson, et al.
The New England Journal of Medicine
|
March 16, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
Margareth C Ozelo, Johnny Mahlangu, K John Pasi, et al.
Journal of the American College of Cardiology
|
September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project
Charles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.
Blood
|
August 16, 2005
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
Charles L Bennett, Denis Cournoyer, Kenneth R Carson, et al.
Research Square
|
October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A
Tom Howard, Marcio Almieda, Vincent Diego, et al.
Genes and Immunity
|
April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A
Marcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Journal of the National Cancer Institute
|
April 28, 2020
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study
Barbara A Conley, Lou Staudt, Naoko Takebe, et al.
Genes and Immunity
|
September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A
Marcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Small (Weinheim an Der Bergstrasse, Germany)
|
July 19, 2012
Microarray with micro- and nano-topographies enables identification of the optimal topography for directing the differentiation of primary murine neural progenitor cells
Aung Aung Kywe Moe, Mona Suryana, Guillaume Marcy, et al.
Journal of Clinical Medicine
|
December 24, 2021
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
Gili Kenet, Yeu-Chin Chen, Gillian Lowe, et al.
The New England Journal of Medicine
|
October 2, 2004
Pure red-cell aplasia and epoetin therapy
Charles L Bennett, Stefano Luminari, Allen R Nissenson, et al.
The New England Journal of Medicine
|
March 16, 2022
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
Margareth C Ozelo, Johnny Mahlangu, K John Pasi, et al.
Journal of the American College of Cardiology
|
September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project
Charles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.
Blood
|
August 16, 2005
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
Charles L Bennett, Denis Cournoyer, Kenneth R Carson, et al.
Research Square
|
October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A
Tom Howard, Marcio Almieda, Vincent Diego, et al.
Genes and Immunity
|
April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A
Marcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Journal of the National Cancer Institute
|
April 28, 2020
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study
Barbara A Conley, Lou Staudt, Naoko Takebe, et al.
Genes and Immunity
|
September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A
Marcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Page
of 9